YUMANITY THERAPEUTICS INC has a total of 39 patent applications. It increased the IP activity by 450.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are METABOLYS, BASILEA PHARMACEUTICA INT AG and ONCOBIX CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United States | 6 | |
#4 | Canada | 4 | |
#5 | Australia | 3 | |
#6 | Brazil | 3 | |
#7 | Israel | 3 | |
#8 | Republic of Korea | 2 | |
#9 | Singapore | 2 | |
#10 | Mexico | 1 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials | |
#5 | Peptides | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Lucas Matthew | 30 |
#2 | Le Bourdonnec Bertrand | 29 |
#3 | Tardiff Daniel | 29 |
#4 | Pandya Bhaumik | 25 |
#5 | Scannevin Robert | 21 |
#6 | Rhodes Kenneth | 21 |
#7 | Aron Rebecca | 19 |
#8 | Piotrowski Jeff | 19 |
#9 | Wrona Iwona | 18 |
#10 | Ozboya Kerem | 18 |
Publication | Filing date | Title |
---|---|---|
WO2020198026A1 | Compounds and uses thereof | |
WO2020154571A1 | Compounds and uses thereof | |
WO2020150423A1 | Methods for the treatment of neurological disorders | |
TW202017567A | Compositions and methods for the treatment and prevention of neurological disorders | |
WO2019209948A1 | Compounds and uses thereof | |
WO2019209962A1 | Compounds and uses thereof | |
AU2019238326A1 | Compounds and uses thereof | |
CA3083000A1 | Compounds and uses thereof | |
EP3566055A1 | Methods for the treatment of neurological disorders | |
EP3529245A1 | Compounds and uses thereof |